Search Results 711-720 of 21253 for platelets

  1. A Phase 1b/2a Multicenter, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CC-220 as Monotherapy and in Combination with Other Treatments in Subjects with Multiple Myeloma - Mayo Clinic

    Platelet count < 75,000/μL for Part 1. For Part 2; platelet count < 75,000/μL for subjects in whom < 50% of bone marrow nucleated cells are plasma cells ...

  2. Publications - Eva Kubrova - Mayo Clinic

    Platelet Rich Plasma and Platelet-Related Products in the Treatment of Radiculopathy-A Systematic Review of the Literature. Biomedicines. 2022 Nov 04; 10(11) ...

  3. Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS - Mayo Clinic

    Thrombocytopenia with platelets < 30,000/uL or with clinically significant bleeding or bruising and platelets < 50,000/uL;; Neutropenia with an absolute ...

  4. Physical Medicine and Rehabilitation - Doctors - Mayo Clinic

    Jane Konidis, M.D.. Physiatrist. Rochester, MN. Areas of focus: Ultrasound, Nerve hydrodissection, Platelet rich plasma injection, Bone marrow aspirate ...

  5. Sports Medicine - Doctors - Mayo Clinic

    ... Platelet rich plasma injection, Ultraso...und-guided percutaneous fasciotomy, Bone marrow aspirate concentrate injection, Epidural steroid injection ...

  6. Orthopedic Surgery - Doctors - Mayo Clinic

    Jelsing, M.D.. Sports Medicine Specialist. Rochester, MN. Areas of focus: Ultrasound, Platelet rich plasma injection, Soft tissue injection, Joint injection ...

  7. Marianne T. Luetmer, M.D. - Doctors and Medical Staff - Mayo Clinic

    Platelet rich plasma injection; Regenerative medicine therapy; Single-fiber electromyography; Soft tissue injection; Sport specific rehabilitation; Tenotomy ...

  8. Neurology - Clinical trials - Mayo Clinic

    ... platelets ≥ 100,000 /microliter, performed within 7 days prior to the collection. Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects ...

  9. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

    ... platelets). For ANC and platelets, please follow inclusion criteria #6 regarding neutrophils and platelets. History of other active malignancies within 2 ...

  10. Hematology - Clinical trials

    ... platelets ≥ 100,000 /microliter, performed within 7 days prior to the collection. Avelumab In Combination Regimens That Include An Immune Agonist ...